Bayrak, M. Et Al. 2013. Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.15, no.4 , 307-312.

Bayrak, M., Olmez, O. F., Kurt, E., ÇUBUKÇU, E., EVRENSEL, T., Kanat, O., ... Manavoglu, O.(2013). Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.15, no.4, 307-312.

Bayrak, Muharrem Et Al. "Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.15, no.4, 307-312, 2013

Bayrak, Muharrem Et Al. "Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.15, no.4, pp.307-312, 2013

Bayrak, M. Et Al. (2013) . "Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.15, no.4, pp.307-312.

@article{article, author={Muharrem Bayrak Et Al. }, title={Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer}, journal={CLINICAL & TRANSLATIONAL ONCOLOGY}, year=2013, pages={307-312} }